Today Aetion and McKesson announced a strategic collaboration focused on advancing the use of real-world evidence (RWE) in cancer research to benefit patients, regulators, the biopharma industry and payers. The partnership will provide best-in-class solutions in multiple tumor types, including breast, lung and melanoma cancers.
Solutions
![right arrow](/Ontada/images/icons/white-down-arrow.png?v=u3hjhmpNIp8etEtmS7upEeqmDPfsRubUgmP7L488NAo)
Life Sciences
![right arrow](/Ontada/images/icons/blue-right-arrow.png?v=4KFZ6vCSu6sqTp58mSQjR0Tul-I-DKOrhnC2bAf3LXY)
News & Events
![right arrow](/Ontada/images/icons/blue-right-arrow.png?v=4KFZ6vCSu6sqTp58mSQjR0Tul-I-DKOrhnC2bAf3LXY)
More